Valiant Laboratories Ltd

NSE
VALIANTLAB •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Valiant Laboratories Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W Low on Oct 06, 2023
-2.7
TTM PE Ratio
High in industry
66.6
Price to Book Ratio
Below industry Median
7.7
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-1.7
RSI
RSI is mid-range
42.8
MFI
MFI oversold
23.4

Valiant Laboratories Ltd Key Financials

*All values are in ₹ Cr.

Valiant Laboratories Ltd shareholding Pattern

Promoter
74.9%
Foreign Institutions
7.1%
Domestic Institutions
0.5%
Public
17.5%

Valiant Laboratories Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
3
Bearish Moving Averages
8
5Day EMA
176.80
10Day EMA
178.90
12Day EMA
179.80
20Day EMA
182.20
26Day EMA
182.90
50Day EMA
183.40
EMA
NaN
EMA
NaN
Delivery & Volume
Resistance & Support
177.72
Pivot
Resistance
First Resistance
179.48
Second Resistance
181.77
Third Resistance
183.53
Support
First Support
175.43
Second support
173.67
Third Support
171.38
Relative Strength Index
42.76
Money Flow Index
23.45
MACD
-3.14
MACD Signal
-1.60
Average True Range
8.16
Average Directional Index
15.59
Rate of Change (21)
-9.36
Rate of Change (125)
0.00

Valiant Laboratories Ltd Company background

Founded in: 2021
Managing director: Santosh S. Vora
Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or parahydroxyacetanilide C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the firstline therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products. Presently, the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area, Boisar in the State of Maharashtra, with an annual installed capacity of 9,000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area, Palghar, Maharashtra, the Company has an inhouse RD infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora, Director and Dhanvallabh Ventures LLP (DVL). In July, 2022 the Company formed its wholly owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) to diversify the business activities.The Company has come out with a Public Issue of issuing upto 11,556,000 Equity Shares through fresh issue.
Read More

Valiant Laboratories Ltd FAQs

Valiant Laboratories Ltd shares are currently priced at 177.2 on NSE and 177 on BSE as of 2/22/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Valiant Laboratories Ltd [VALIANTLAB] share was 0. The Valiant Laboratories Ltd [VALIANTLAB] share hit a 1-year low of Rs. 162.1 and a 1-year high of Rs. 214.95.

The market cap of Valiant Laboratories Ltd is Rs. 769.93 Cr. as of 2/22/2024 12:00:00 AM.

The PE ratios of Valiant Laboratories Ltd is 69.14 as of 2/22/2024 12:00:00 AM.

The PB ratios of Valiant Laboratories Ltd is 2.98 as of 2/22/2024 12:00:00 AM

You can easily buy Valiant Laboratories Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage